Cargando…
Osteosarcoma Pathogenesis Leads the Way to New Target Treatments
Osteosarcoma (OS) is a rare condition with very poor prognosis in a metastatic setting. Basic research has enabled a better understanding of OS pathogenesis and the discovery of new potential therapeutic targets. Phase I and II clinical trials are already ongoing, with some promising results for the...
Autores principales: | Fernandes, Isabel, Melo-Alvim, Cecília, Lopes-Brás, Raquel, Esperança-Martins, Miguel, Costa, Luís |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831017/ https://www.ncbi.nlm.nih.gov/pubmed/33467481 http://dx.doi.org/10.3390/ijms22020813 |
Ejemplares similares
-
Genomic Profiling of Sarcomas: A Promising Weapon in the Therapeutic Arsenal
por: Lopes-Brás, Raquel, et al.
Publicado: (2022) -
Management of Unresectable Localized Pelvic Bone Sarcomas: Current Practice and Future Perspectives
por: Soares do Brito, Joaquim, et al.
Publicado: (2022) -
Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Turning the Magnifying Glass on Rare and Aggressive Entities
por: Esperança-Martins, Miguel, et al.
Publicado: (2023) -
Biology and pathogenesis of human osteosarcoma
por: de Azevedo, Judson Welber Veríssimo, et al.
Publicado: (2020) -
Alendronic Acid as Ionic Liquid: New Perspective on Osteosarcoma
por: Teixeira, Sónia, et al.
Publicado: (2020)